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Abstract
Background and Aims: C/EBP homologous protein (CHOP) plays pro-apoptotic roles in the integrated stress response.
Recently, a tumor suppressive role for CHOP was demonstrated in lung cancer via regulation of tumor metabolism. To
explore the role of CHOP in hepatocarcinogenesis, we induced hepatocellular carcinoma (HCC) in wild type (wt) and CHOP
knockout (KO) mice using the carcinogen N-diethylnitrosamine (DEN).
Results: Analysis of tumor development showed reduced tumor load, with markedly smaller tumor nodules in the CHOP KO
animals, suggesting oncogenic roles of CHOP in carcinogen-induced HCC. In wt tumors, CHOP was exclusively expressed in
tumor tissue, with minimal expression in normal parenchyma. Analysis of human adenocarcinomas of various origins
demonstrated scattered expression of CHOP in the tumors, pointing to relevance in human pathology. Characterization of
pathways that may contribute to preferential expression of CHOP in the tumor identified ATF6 as a potential candidate.
ATF6, a key member of the endoplasmic reticulum stress signaling machinery, exhibited a similar pattern of expression as
CHOP and strong activation in wt but not CHOP KO tumors. Because HCC is induced by chronic inflammation, we assessed
whether CHOP deficiency affects tumor-immune system crosstalk. We found that the number of macrophages and levels of
IFNc and CCL4 mRNA were markedly reduced in tumors from CHOP KO relative to wt mice, suggesting a role for CHOP in
modulating tumor microenvironment and macrophage recruitment to the tumor.
Conclusion: Our data highlights a role for CHOP as a positive regulator of carcinogen-induced HCC progression through a
complex mechanism that involves the immune system and modulation of stress signaling pathways.
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Introduction
Hepatocellular carcinoma (HCC) is the fifth most common
cancer and the third cause of cancer-related deaths worldwide [1].
Chronic hepatic inflammation and cirrhosis is responsible for 90%
of HCC cases. Current standard treatments for HCC include liver
transplantation and surgical resection, local ablative therapies
including radiofrequency ablation and transarterial chemoembo-
lization, and targeted therapy with the tyrosine kinase inhibitor,
sorafenib. These strategies are often ineffective and are accompa-
nied by a high incidence of recurrence and poor prognosis for the
majority of patients with HCC [2]. The underlying molecular
mechanisms of inflammation-induced carcinogenesis are under
intensive research but have been only partially elucidated.
The endoplasmic reticulum (ER) is the cellular organelle
responsible, among other functions, for preparing and directing
proteins into secretory pathways via its folding properties. Under
homeostatic conditions, the ER folding capacity matches the load
of its client proteins. However, under certain conditions this
homeostasis is disturbed resulting in the accumulation of unfolded
or misfolded proteins, referred to as ER stress. An ER-to-nucleus
signaling pathway, collectively called the unfolded protein
response (UPR), emanates from the ER to relieve cells of the
stress condition. The mammalian UPR is regulated by three ER
trans-membrane sensors: the inositol requiring enzyme 1 (IRE1),
the double-stranded RNA-activated protein kinase–like ER kinase
(PERK), and the activating transcription factor 6 (ATF6) [3]. Each
sensor controls a downstream signaling pathway that contributes
PLOS ONE | www.plosone.org 1 December 2013 | Volume 8 | Issue 12 | e81065to reducing ER stress and restoring homeostasis. Activation of the
UPR, when transient, leads to attenuation of translation, mRNA
and ER protein degradation, increased autophagy and increment
of the ER folding capacity by synthesis of new chaperone proteins.
However, when the stress persists, programmed cell death ensues
[4].
Various mechanisms connect the UPR to the apoptotic
machinery. A key regulator of ER stress-induced apoptosis is C/
EBP homologous protein (CHOP). This 29 kDa protein has been
identified in the DNA damage inducible transcript genetic screen,
as belonging to the growth arrest DNA damage (GADD) protein
family. Although this transcription factor cannot bind DNA
directly because of the presence of proline and glycine residues in
its basic region that disrupt its DNA binding activity, it can
regulate gene expression by forming hetero-dimers with other
proteins from the C/EBP family or other transcription factors,
acting as an activator or inhibitor of gene transcription [5].
Under normal conditions, CHOP is minimally expressed and
can be found in the cytoplasm. In response to DNA damage, ER
stress or other stress responses, CHOP is induced and translocates
to the nucleus. CHOP is an effector of the PERK and ATF6 arms
of the UPR, and has been shown to regulate apoptosis by
mechanisms that include induction of oxidative stress, disturbing
iron homeostasis, down-regulation of the anti-apoptotic protein
Bcl2 and up-regulation of the death receptor 5 (DR5) [6–8]. A
recent study utilizing chromatin immunoprecipitation sequencing
(ChIP-seq) techniques, demonstrated that CHOP promotes ER
stress-mediated apoptosis primarily by enhancing protein synthesis
and oxidative stress. Direct binding of CHOP to gene promoters
that participate in apoptosis was not observed [9]. Furthermore,
nuclear localization of CHOP was shown to directly regulate
activation of genes associated to cell movement, growth and
proliferation, suggesting a more diverse role of CHOP in cellular
processes [10,11].
The role of ER stress in cancer is controversial. UPR signaling
in endothelial cells was demonstrated to promote angiogenesis by
controlling VEGF expression [12,13]. Studies in primary cells
demonstrated that the PERK pathway is critical for transforma-
tion, suggesting that UPR promotes tumorigenesis [14]. The role
of ER stress-mediated apoptosis in cancer has not been widely
explored, either. One recent observation, using a RAS-driven lung
cancer mouse model, indicates that CHOP serves as a barrier for
tumor development, primarily by promoting cell death when
nutrients become a limiting factor for tumor growth [15].
In the present study we explored the role of CHOP in
diethylnitrosamine (DEN)-induced HCC by utilizing wt and
CHOP KO mice. Unexpectedly, deletion of CHOP resulted in
significantly smaller tumors, suggesting that CHOP operates as an
oncogene in HCC, rather than a tumor suppressor gene as
reported for lung cancer. The IRE1 and PERK arms of the UPR
were minimally activated. However, the ATF6 arm showed
marked tumor-specific activation. We further show that CHOP is
activated in human tumors of various origins. Macrophage
infiltration into CHOP KO tumors and inflammatory cytokine
and chemoattractant levels were reduced relative to the wt
controls. Our data reveal a new role for CHOP in hepatic
tumorigenesis and highlights the duality of ER stress in cancer.
Results
CHOP Promotes Tumor Progression
To explore the role of CHOP in HCC initiation and
progression, 12 wt and 12 CHOP KO mice were injected
intraperitoneally with DEN at the age of 15 days. We used an
accelerated protocol of DEN-induced tumors as previously
described by Huang et al, and mice were sacrificed at the age of
5 months [16]. Livers were removed and tumors were assessed
macroscopically and histologically. For both genotypes, tumors
were found in 11 of the 12 DEN-treated mice. The number of
tumor nodules present in a defined area of liver tissue was
compared between wt and CHOP KO mice. No significant
differences were found in the number of tumor nodules. However,
nodule size/total area was approximately 10 fold smaller in the
CHOP KO compared to wt mice, as quantified using ImageJ
software (3.93%63.3% and 34.57%615.8% respectively)
(Figure 1A).
Because tumor size is related to cell proliferation capacity, we
stained the tissue for the nuclear protein Ki67, a marker of cell
cycle activation. Our results show that expression of Ki67 was
significantly higher in tumors from wt as compared to CHOP KO
mice (13.5% vs. 2.27% of total cells, as quantified by ARIOL,
p,0.05 (Figure 1B). These results indicate that CHOP promotes
tumor cell proliferation. To verify the expression of CHOP in the
DEN-induced wt tumors, sections that contain the borders
between the tumor and the normal parenchyma were stained by
immunohistochemistry (IHC) for CHOP. Remarkably, CHOP
expression was clearly confined to the nuclei of the tumor cells,
and was absent in the adjacent parenchymal cells. Interestingly,
despite robust expression of CHOP in the tumor (Figure 1C), we
did not observe evidence of apoptosis, as indicated by the absence
of active caspase 3 expression (Figure 1D). As a positive control for
apoptosis we analysed the livers 24 h after DEN-induced DNA
damage (Figure 1E). We conclude that CHOP is specifically
expressed in HCC tumors in a manner that does not promote
apoptosis. Expression of CHOP plays a pro-tumorigenic role.
Nuclear CHOP is Observed in Human Adenocarcinomas
To investigate the relevance of our mouse data to human
pathology, CHOP expression was assessed in human HCC. We
obtained HCC biopsies from 9 patients. Nuclear staining for
CHOP was observed in 6 of the 9 samples. In contrast, CHOP
was not expressed in adjacent human parenchyma, supporting its
exclusive tumor expression (Figure 2).
Further analysis of human tumors demonstrated that CHOP
expression was not restricted to HCC. We found robust CHOP
expression in prostate and pancreas adenocarcinomas. Again,
CHOP was predominantly expressed in the tumor tissue and
minimally in the surrounding normal parenchyma (Figure S1 in
File S1). These data suggest that CHOP may also play a pro-
tumorigenic role in various other types of human carcinomas.
UPR is Mildly Activated in DEN-induced HCC
Several mechanisms contribute to CHOP expression. CHOP is
transcriptionally induced downstream of ATF4, the hub protein of
the integrated stress response (IRS) [17]. In addition, CHOP is a
direct target of ATF6 [18], and eIF2a phosphorylation on Serine
51 was also shown to promote CHOP translation [19]. We
assessed the contribution of the different arms of the UPR to
CHOP expression in the DEN-induced tumors in comparison to
their parenchyma in a pair-wise tumor/parenchyma manner.
CHOP mRNA levels were increased 6-fold in the tumors as
compared to parenchyma, implicating transcription control rather
than translation or degradation as the main contributor to CHOP
expression in the tumors (Figure 3A). This was corroborated by a
lack of increase of PERK phosphorylation or its eIF2a substrate in
the tumors. Interestingly, in the CHOP KO animals, eIF2a
phosphorylation was induced in the tumors, supporting a role of
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(Figure 3B).
Next, we assessed the existence of ER stress conditions in the
tumors. The ratios of phosphorylated IRE1 to total IRE1 levels
were similar between wt tumors and parenchyma (Figure 3B).
Furthermore, there was a non-significant increase in XBP-1
mRNA splicing and lack of induction of the XBP-1 specific target
genes, ERdj4 and p58IPK [20]. These findings point to a minimal
contribution of the IRE1 arm of the UPR to the induction of
CHOP expression in the wt tumors. We were not able to detect
the endogenous ATF4 protein levels using various commercial
antibodies. Analysis of ATF4 mRNA indicated a moderate
increase. However, since ATF4 expression is regulated primarily
at the translation level [21], our data cannot confirm nor exclude
the contribution of ISR to CHOP expression.
ATF6 is converted into a transcription factor by regulated intra-
membrane proteolysis in response to ER stress, liberating its
50 kDa cytoplasmic N-terminus fragment for transcription induc-
tion [22]. Immunoblotting analysis showed robust cleavage of
ATF6 in the wt tumors, as compared to reduced expression in the
parenchyma (Figure 3B). We therefore decided to explore the
activation of ATF6 by IHC in the DEN-induced tumors, as well as
in the various human adenocarcinomas. An isolated strong nuclear
staining was observed in tumor tissue (Figure S1 & S2 in File S1).
Our data identifies ATF6 as a putative inducer of CHOP in
tumors. The mechanisms governing ATF6 selective activation in
the tumors in contrast to the mild activation of the other two arms
of the UPR remain to be elucidated.
CHOP Promotes Inflammation and Macrophage
Infiltration into the DEN-induced Tumors
Clinically, HCC usually develops on the background of chronic
hepatic inflammation, induced by hepatitis viruses, alcohol, fat or
exposure to other hepatotoxic substances. DEN-induced tumors
share similar pathogenesis, in which pro-inflammatory cytokines
such as IL-6 and TNFa promote tumor development [23]. A
common observation in HCC and other solid tumors is the
infiltration of macrophages [24–30]. We therefore assessed the
level of pro-inflammatory cytokines and infiltration of immune
cells in tumors of wt and CHOP KO mice. Interferon gamma
(IFNc) mRNA level was significantly lower (Figure 4A) while those
of IL-6 and TNFa were similar in wt and CHOP KO tumors
respectively. Analysis of immune cell infiltrates demonstrated
similar numbers of CD3-positive T lymphocytes and Ly6B.2-
positive neutrophils in wt and CHOP KO livers (Figure 4B). Wt
tumors showed a rich macrophage presence as detected by F4/80
staining. In contrast, a marked decrease in the number of
infiltrating macrophages was observed in CHOP KO tumors (80
macrophages/zone vs. 36 macrophages/tumor zone respectively
p=0.012) (Figure 5A). These data are in agreement with the
reduced IFNc levels, as macrophages infiltration into the DEN
tumors is dependent on intact IFNc signalling [31]. Finally, we
analysed the mRNA levels of CCL3 and CCL4, chemokines
involved in macrophage recruitment, by qPCR. CCL4 levels were
reduced in the CHOP KO as compared to wt controls (Figure 5B).
These data demonstrate a combined defect in the inflammatory
response in the CHOP KO tumors manifested by reduced
Figure 1. CHOP KO mice develop smaller HCC nodules. A. Shown is a representative development of HCC in WT and CHOP KO livers (red lines
mark tumors nodules). Tumor area was calculated as a percentage of total analyzed liver area (n=8) (right panel). B. Cell cycle activation was assessed
by Ki67 staining (red arrows indicate positive staining). Slides were scanned and stained area was quantified automatically using ARIOL software
(n=8). C. Histological sections of WT and CHOP KO HCC were stained for CHOP (red arrows), the green dotted line demarks tumor borders. D.
Histological sections of DEN induced HCC were stained for activated caspase 3 (upper panel), E. staining for active caspase 3 24 h following DEN
injection was used as a positive control (lower panel).
doi:10.1371/journal.pone.0081065.g001
Figure 2. Nuclear CHOP in observed in human HCC. Human samples were stained for CHOP, nuclei were visualized by hematoxylin staining
(red arrows).
doi:10.1371/journal.pone.0081065.g002
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induced-carcinogenesis.
Discussion
HCC is a leading cause of morbidity and mortality. Although
much is known about the role of inflammation in hepatic
carcinogenesis, the specific role of ER stress, and individual
UPR regulator proteins in this process are largely unexplored.
CHOP is a key pro-apoptotic member of the UPR. Recently its
role in modulating other cellular processes has come to light,
including involvement in hepatocyte proliferation and inflamma-
tory cell movement [32].
Under normal conditions, CHOP is expressed at a low level in
the cytoplasm where it has been suggested to exist in a non-
functional state. However, following homeostatic perturbations
such as ER and oxidative stress induction, CHOP levels markedly
increase and the protein becomes active following nuclear
translocation, a process that requires accessory molecules [10].
Following nuclear translocation, CHOP undergoes hetero and
homo-dimerization and acquires DNA binding capacities in trans,
which allow it to promote or inhibit gene expression. The context
in which CHOP is expressed largely determines cellular commit-
ment and fate. Recent data shows that under strong ER stress
conditions inflicted by tunicamycin treatment in fibroblasts,
CHOP primarily partners with ATF4. This leads to the
dysregulation of protein synthesis and promotion of oxidative
stress, cumulatively promoting apoptosis [9]. In the liver, under a
challenge of tunicamycin or proteasome inhibition, CHOP
suppresses lipid synthesis by outcompeting C/EBPa and C/EBPb
DNA binding [33]. However, if instead of interfering with protein
folding and degradation, mice are fed with methionine-choline
deficient diet, which promotes the development of liver steatosis
and nonalcoholic fatty liver disease (NAFLD), CHOP protected
against NAFLD in a mechanism that involved exacerbated
apoptosis of liver macrophages [34].
In the present study we assessed the role of CHOP in a well-
characterized carcinogen-induced HCC model by using CHOP
KO and wt mice. While similar numbers of malignant nodules
were observed in CHOP KO, the nodules were markedly smaller.
Furthermore, CHOP was exclusively expressed in the tumor cells,
but not in the normal parenchyma (Figure 1). This exclusive
expression pattern was also observed in human tumors of various
origins, but was not universal and not as pronounced as in the
murine model (Figure 2 and Figure S1 in File S1). This different
histological appearance might be related to the fact that the
human samples were all taken during liver resection and represent
advanced disease, most usually on the background of cirrhotic
changes. While in the mice histological analysis was performed
early in the disease course when cirrhotic changes have not yet
developed. Furthermore, tumor induction by DEN is a singular
event and is not fully reminiscent of human tumors in which
multiple pathways are activated over prolonged periods, some of
which may inhibit or reduce CHOP expression. All these suggest
that multiple mechanisms may impinge on CHOP expression in
the human tissues and thus affect its heterogeneous expression.
CHOP activation was not universal within the human samples,
suggesting that other oncogenic pathways induce hepatic carcino-
genesis in a CHOP-independent manner. The tumors we
examined were from patients with HCC in cirrhotic livers of
various underlying causes (HCV, HBV, NASH etc.). Due to the
limited number of samples, this study cannot assess the contribu-
tion of specific underlying liver disease etiologies to CHOP
activation in human tumors.
The observation that CHOP, a pro-apoptotic protein supports
HCC tumorigenesis was unexpected. Cell death plays a dual role
in the DEN-induced carcinogenesis process. During the early
stages of development, apoptosis initiates tissue reconstruction
after the DNA damage inflicted by the carcinogen, a process
important for tumor initiation. In this phase apoptosis contributes
to local inflammatory conditions and release of tumor promoting
cytokines, such as TGFa. Later, when micro-tumors are formed,
apoptosis limits tumor progression, especially under hypoxic
conditions or lack of nutrients. Accordingly, over-expression of
the anti-apoptotic gene Bcl2 inhibits DEN-induced liver carcino-
genesis, primarily due to attenuation of tumor initiation [35].
Thus, it may be that the absence of CHOP interferes with the
Figure 3. Differential activation of UPR pathways in the DEN-induced HCC mouse model. A. Real-time PCR analyses of UPR target genes.
Tumor gene expression was compared to its corresponding parenchyma (n=8, p,0.01). B. Western Blot analysis of total liver extract for different UPR
proteins (n=5, p,0.05). 20 mg were loaded for Bip, eIF2, CHOP, p97 analysis; 40 mg were loaded for all other UPR markers.
doi:10.1371/journal.pone.0081065.g003
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model [36]. The fact that a similar number of tumor nodules
develop in wt and CHOP KO mice, suggest that there may be a
tumor initiating event that is CHOP-independent but once
formed, lack of CHOP is not permissive for growth. It may be
that CHOP is more an accelerant of HCC rather than an inducer
and is only involved in the tumor progression phase.
In the analysis of factors that may induce CHOP preferen-
tially in the tumor, we characterized ER stress as a likely factor.
In the DEN model, tumors develop over a 5–9 month period,
the conditions of ER stress, if triggered are chronic in nature,
rather than acute as explored experimentally in the aforemen-
tioned studies. Accordingly, we have not observed robust
activation of the PERK and IRE1a pathways of the UPR,
both of which strongly affect liver metabolism (Figure 3)
[37,38]. In contrast, the nuclear fragment of ATF6 was
expressed preferentially in the wt tumors and much less in
the parenchyma. Furthermore, ATF6 cleavage was milder in
CHOP KO, alluding to a feedback mechanism that may exist
between CHOP and ATF6 in tumors (Figure 3). Thus our data
implicates ATF6 as a factor upstream to CHOP. It is
conceivable that the suppression of HCC progression in the
CHOP KO mice may also be related to complex feedback
loops that CHOP relays to the UPR machinery.
In the DEN model, HCC development is affected by the
immune system through secretion of cytokines (primarily TNFa
and IL-6) and lipid eicosanoid mediators [39], all of which are
robustly produced by Kupffer cells, the liver-resident macrophag-
es. It is therefore not surprising that Kupffer cells are strong
instigators of HCC [24]. We therefore analyzed the presence of
immune cells in wt and CHOP KO tumors. While neutrophils and
T cells were present in similar numbers in both tumor genotypes
(Figure 4), macrophages were virtually absent from the CHOP
KO tumors (Figure 5). It is not clear what upstream signals
contribute to this phenotype. Quantitative PCR analysis pointed
that the macrophage attractant chemokine CCL4 was diminished
in the CHOP KO tumors as a possible upstream signal controlled
by CHOP (Figure 5). Cytokine profiling indicated changes in
IFNc expression as well (Figure 4A). Whether these are the sole
regulators of the differential macrophage infiltration into wt and
CHOP KO tumors is not known. The data presented here
counter-intuitively highlights CHOP as a potential oncogenic
Figure 4. Cytokine levels and immune cell infiltration into DEN-induced HCC. A. Analysis of cytokines mRNA levels in tumor and
parenchyma of WT and CHOP2/2 mice (n=5, p,0.01 for statistical significance). B. Histological sections of liver tissue slides were stained for T cells
(anti-CD3) and neutrophils (anti-Ly6B.2). The total number of CD3 or Ly6B.2 positive cells in wt and CHOP 2/2 tumor and parenchyma were counted
(n=5 for each genotype).
doi:10.1371/journal.pone.0081065.g004
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carcinogenesis via mechanisms involving UPR signaling, primarily
a crosstalk with ATF6, and an effect on macrophage recruitment
into the tumors. Our data marks CHOP as a possible target for
drug development in HCC.
Materials and Methods
Ethics Statement
Animal care and experiments were approved and conducted in
accordance with the guidelines of the Authority for Biological and
Biomedical Models of the Hebrew University, approval number
MD-10-12531-4. The Institutional Animal Care and Use Com-
mittee (IACUC) specifically approved the animal part of the study.
Collection of human tissues was approved by the Ethics committee
of the Tel-Aviv Medical Center, Tel-Aviv Israel. Because tissues
were unidentified, according to the declaration of Helsinki, no
written informed consent was necessary. The ethics committee
specifically waived the need for written informed consent from the
participants. Approval number is 0352-12-TLV.
Animal Model
C67BL/6J and CHOP2/2 (on a C57BL/6J background)
animals were purchased from Jackson laboratory (Bar Harbor,
ME, USA), and bred in a pathogen free facility. Fourteen days
after birth, animals were treated with a single intra-peritoneal
injection of diethylnitrosamine (99% purity, Sigma-Aldrich,
cat#73861, MO, USA) at a dose of 10 mg per gram diluted
in 0.9% saline. Starting two weeks after DEN injection, mice
were treated with biweekly injections of 1,4-Bis-[2-(3,5-dichlor-
opyridyloxy)]benzene (TCPOBOP) (98% purity, Sigma-Aldrich,
cat#T1443, MO. USA) at a concentration of 3 mg per gram
diluted in corn oil as previously described [40]. Five months
after birth, animals were sacrificed, RNA and protein extracted,
and tissue was preserved in 4% paraformaldehyde for paraffin
fixation.
RNA Isolation and Quantitative PCR
Total RNA from tissue was isolated using TriReagent (Sigma-
Aldrich) according to the manufacturer’s protocol. cDNA was
generated using High Capacity cDNA Reverse Transcription kit
(Applied Biosystem, CA, USA) from 2 mg of RNA with random
hexameric primers. Quantitative PCR was carried out using
Kapa syber fast qPCR kit (KapaBiosystems, MA,USA) using the
primers specified in Table S1 in File S1. Ubiquitin C was used
as the house keeping reference gene for all qPCR analyses. All
reactions were performed at annealing temperature of 58uC.
Figure 5. Chemokine levels and macrophages infiltration into DEN-induced HCC. A. Histological sections of WT and CHOP KO livers were
stained for the macrophage marker F4/80. Total number of F4/80 positive cells (red arrows) were counted in seven different tumor zones in each
sample (n=5 of both genotypes, p,0.05). B. Analysis of mRNA expression of chemokines in tumor and parenchyma of WT and CHOP2/2 mice.
doi:10.1371/journal.pone.0081065.g005
CHOP Promotes Hepatic Carcinogenesis
PLOS ONE | www.plosone.org 7 December 2013 | Volume 8 | Issue 12 | e81065Western Blotting
Liver tissue was lysed in RIPA lysis buffer. Protein samples were
then separated by SDS–polyacrylamide gel electrophoresis and
transferred to PVDF membranes. Subsequently, membranes were
blocked and probed with specific antibodies (Table S2 in File S1)
followed by secondary horseradish peroxidase-conjugated anti-
bodies. Reactive bands were visualized using an enhanced
chemiluminescence reaction and subjected to densitometric
analysis relative to p97.
Immunohistochemistry
Tissue was fixed in 4% formaldehyde for 16 h and dehydrated
in 70% ethanol. Tissue was then embedded in paraffin and 10 mm
sections were used for analysis. Sections were deparaffinized in
histo-clear (Kaltek, Padova, Italy), and then rehydrated in serial
washes with ethanol gradient. Retrieval was performed in 10 mM
citrate buffer, pH=6 at 120uC and 1.8 atm for 3 minutes.
Secondary antibody kit MACH3 (Biocare Medical, CA, USA) was
used for detection and amplification of first antibody signal. After
substrate reaction, nuclei were stained using haematoxylin.
Samples were then dehydrated in serial washes with ethanol
gradient and sealed.
Staining Quantification and Tumor Measuring
Tumors and total area was calculated using ImageJ software
(rsbweb.nih.gov/ij) applied to scanned images from haematoxylin
and eosin staining (augment 6 5). IHC positive staining was
measured by automated image analysis quantification (Ariol-
SL50).
Statistical Analysis
Statistical significance between groups was assessed by one-way
ANOVA adjusted for multiple comparisons and tested for normal
distribution. Data are expressed as means 6 standard deviations.
Triplicate determinations were performed in all the real-time
experiments, and all experiments were repeated at least three
times. A p-value equal or less than 0.05 was considered to be
statistically significant.
Supporting Information
File S1 Table S1. List of antibodies. Table S2. Primers
list for qPCR. Figure S1. ATF6 is activated in human
HCC. Figure S2. CHOP and ATF6 are activated in
different human adenocarcinomas.
(PDF)
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